Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/eNsiCfbwocgqqMcZJjPA

October 17, 2013
ASNC SmartBrief Special Report
News for nuclear cardiology and cardiovascular imaging professionals
Sign up|Forward|Archive|Advertise

ASNC SmartBrief Special Report:
Clinical science and more from ASNC2013
This year's conference was a special one for ASNC as the society marked its 20th anniversary. This special report explores the key topics of the conference, themes that have resonated throughout ASNC initiatives over the past two decades: exploring the best of clinical science, promoting responsible and evidence-based patient care and making your practice the best it can be. Check out ASNC SmartBrief for more essential updates in cardiology with a special focus on cardiovascular imaging.
Clinical Update 
  • ASNC2013: Where nuclear cardiology is headed
    Since the first nuclear scan was performed in the 1970s, "nuclear cardiology has faced a lot of trials and tribulations," said ASNC2013 program chairman Dr. Prem Soman, including worries about radiation exposure, cuts in reimbursement and more. New cameras and tracers, repurposing of techniques in new clinical areas and a proactive approach to radiation exposure and appropriate use have positioned the field for success in the rapidly changing world of health care, Soman said ahead of the meeting. MedPage Today (free registration) (9/25) LinkedInFacebookTwitterEmail this Story
  • Heart scans yield important data on GI health, cancer and more
    SPECT/CT tests often yield incidental findings, and a study reported at ASNC2013 suggests reporting those data to referring doctors might help improve care. In 94% of SPECT/CT MPI studies, incidental findings were noted, including gastrointestinal issues in 34% of cases and pulmonary issues in 32% of scans. Extensive atherosclerosis was seen among half of patients, and possible cancer was detected in one-fifth of cases. Physician's Weekly (9/27) LinkedInFacebookTwitterEmail this Story
  • Quantitative approach may boost multivessel disease detection
    A new quantitative PET method that measures myocardial blood flow may spot evidence of multivessel heart disease missed with standard myocardial perfusion imaging using PET, according to a study presented at ASNC2013. "Stress myocardial blood flow could form the basis of a risk prediction score beyond visual myocardial perfusion imaging, which could then be integrated along with other adjunct markers into clinical software for detection of multivessel coronary artery disease," said Cleveland Clinic researcher Dr. Jun-Yang Lou. MolecularImaging.net (10/3) , MedPage Today (free registration) (9/30) LinkedInFacebookTwitterEmail this Story
  • Other News
Astellas is proud to support the American Society of Nuclear Cardiology.
Visit www.us.astellas.com
Patient Focus 
  • Who needs MPI for angina?
    A study presented at ASNC2013 affirms the safety of limiting the use of myocardial perfusion imaging in low-risk angina patients to those who fail an exercise stress test, allowing for cost savings and reduced radiation exposure. Patients who passed a stress test, were younger than 65 and had normal ECG findings and no history of coronary artery disease were eligible to skip MPI, a strategy that could lower costs and limit radiation exposure. However, MPI findings for those not eligible to skip the test were normal in 94.6% of cases, suggesting additional criteria might be warranted, according to one expert. Physician's Weekly (9/30) , MedPage Today (free registration) (9/30) LinkedInFacebookTwitterEmail this Story
  • UltraSPECT platform meets ASNC guidelines for low dosage
    UltraSPECT is promoting research from St. Luke's-Roosevelt Hospital in New York that assigned 257 participants to a full-dose myocardial perfusion imaging protocol and 205 to a half-dose protocol. Researchers used UltraSPECT's Wide Beam Reconstruction algorithm-based Xpress.Cardiac tool and found that 77% of tests that used the low-dose protocol delivered a radiation dose of less than 9 mSv. AuntMinnie.com (free registration) (9/27) LinkedInFacebookTwitterEmail this Story
  • Other News
Your Practice 
  • Should your practice go off-guideline for MPI?
    Although abnormal MPI findings in a scan that qualified as inappropriate under 2009 guidelines were associated with greater risk of a later major adverse cardiac event, confidence intervals were wide and the absolute number of MACE was low, suggesting practices should stick with the guidelines, according to data presented at ASNC2013. Outcomes were tracked for an average of 27 months. MedPage Today (free registration) (10/1) LinkedInFacebookTwitterEmail this Story
  • Other News
20 Years of Patient-Centered Care: Looking to the Future 
  • What's coming in cardiovascular imaging?
    Dr. Marcelo Di Carli of Harvard Medical School says a number of agents under development hold potential for cardiac imaging. PET agent F-18 flurpiridaz has shown high myocardium extraction in clinical studies, and it can be distributed on a unit-dose basis, meaning it would be available to more practices and patients. Iodine-123 metaiodobenzylguanidine, being developed for SPECT, may improve risk stratification of heart failure, Di Carli added. Agents that assess inflammation in atherosclerotic plaques are also coming. CardiovascularBusiness.com (9/17) LinkedInFacebookTwitterEmail this Story
  

Product announcements appearing in SmartBrief are paid advertisements and do not reflect actual ASNC endorsements. The news reported in SmartBrief does not necessarily reflect the official position of ASNC.
 
Subscriber Tools
   
Print friendly format  | Web version  | Search past news  | Archive  | Privacy policy

Advertise
Account Director: Meryl Harold (202) 407-7828
 
Read more at SmartBrief.com
 
 
 Recent ASNC SmartBrief Issues:   Lead Editor: Melissa Turner
   
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information